Literature DB >> 14527912

Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment, and outcome.

Calvin H L Law1, Alice C Wei, Sherif S Hanna, Mohamed Al-Zahrani, Bryce R Taylor, Paul D Greig, Bernard Langer, Steven Gallinger.   

Abstract

BACKGROUND: The diverse natural history of renal cell carcinoma (RCC) includes metastases to the pancreas, a very unusual site for distant spread of other cancers. Considering the relatively indolent behavior of some cases of metastatic RCC, pancreatic resection is offered to select patients.
METHODS: We reviewed the records of patients at three affiliated university hospital centers who had prior nephrectomy for RCC and subsequent pancreatic resection of metastases.
RESULTS: Fourteen patients--9 women and 5 men with a median age of 63.8 years--underwent a total of 15 pancreatic resections for metastatic RCC. Nine (64%) had solitary metastases. The median interval from nephrectomy to diagnosis of pancreatic metastases was 83 months. The median size of metastases was 4.6 cm. There was one perioperative death. Pancreatic recurrence occurred in five patients (36%), and one patient underwent repeat resection. At a median follow-up of 32 months, seven patients (50%) are alive without evidence of disease, and four patients (28%) are alive with recurrent disease.
CONCLUSIONS: Resection of pancreatic metastases from RCC is associated with long-term survival and should be considered for patients in whom complete resection is possible.

Entities:  

Mesh:

Year:  2003        PMID: 14527912     DOI: 10.1245/aso.2003.02.003

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  34 in total

1.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Metastatic renal cell carcinoma to the pancreas.

Authors:  Harish Lavu; Charles J Yeo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

3.  Surgical resection of metastasis to the pancreas.

Authors:  Dong Do You; Dong Wook Choi; Seong Ho Choi; Jin Seok Heo; Woo Suk Kim; Cheon Yu Ho; Hyung Geun Lee
Journal:  J Korean Surg Soc       Date:  2011-04-12

4.  Unexpected Prolonged Survival After Extended and Emergent Resection of Pancreatic Metastases from Renal Cell Carcinoma.

Authors:  Stefania Brozzetti; Antonio V Sterpetti
Journal:  J Gastrointest Cancer       Date:  2019-12

5.  Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.

Authors:  Sarathi Kalra; Bradley J Atkinson; Marc Ryan Matrana; Surena F Matin; Christopher G Wood; Jose A Karam; Pheroze Tamboli; Kanishka Sircar; Priya Rao; Paul G Corn; Nizar M Tannir; Eric Jonasch
Journal:  BJU Int       Date:  2015-07-06       Impact factor: 5.588

Review 6.  Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?

Authors:  Franz Sellner
Journal:  Clin Exp Metastasis       Date:  2018-06-12       Impact factor: 5.150

7.  Metastasis to the pancreas--an indication for pancreatic resection?

Authors:  S Eidt; M Jergas; R Schmidt; M Siedek
Journal:  Langenbecks Arch Surg       Date:  2007-01-23       Impact factor: 3.445

Review 8.  [Palliative and supportive therapy in cases of renal cell carcinoma].

Authors:  M Kurosch; S Buse; J Bedke; N Wagener; A Haferkamp; M Hohenfellner
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

9.  Surgery for secondary tumors of the pancreas.

Authors:  Faisal S Dar; Samrat Mukherjee; Satyajit Bhattacharya
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Solitary pancreatic metastasis from renal cell carcinoma 6 years after nephrectomy.

Authors:  Hussein Hassan Okasha; Emad Hamza Al-Gemeie; Reem Ezzat Mahdy
Journal:  Endosc Ultrasound       Date:  2013-10       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.